SmartTab, a digital medicine drug delivery company is pleased to announce that it will present at MedCity Precision Medicine INVEST Conference on June 9-11th, 2021. SmartTab's Founder and CEO will present and discuss its wireless capsule medication delivery technology to an audience of sophisticated healthcare investors.
MedCity INVEST Precision Medicine will bring together regional and national stakeholders across hospitals, insurers, pharma, health IT, and medtech to discuss new developments in precision medicine, the reality on the ground, and what needs to happen for more widespread adoption and integration of these innovative technologies.
Article on MedCity News announcing the Startups taking part in the Precision Medicine pitch competition.
This conference gathers all sectors of healthcare to provide the most accurate picture of the future of precision medicine, uniting active investors with corporate business development executives to facilitate investment opportunities with promising early-stage startups. Bringing together regional and national stakeholders across hospitals, insurers, pharma, health IT, and medtech to discuss new developments in precision medicine, the reality on the ground, and what needs to happen for more widespread adoption and integration of these innovative technologies.
SmartTab's CEO, Robert Niichel stated, "We are looking forward to discussing SmartTab's innovative smart therapeutics delivery solution for the treatment of diabetes and Crohn's with industry leaders and investors at the Precision Medicine Showcase. This is a unique opportunity to present our ingestible technologies, oral biologics and targeted therapeutic platform to pharma industry executives, venture capital funds and angel investors."
About MedCity INVEST Precision Medicine
MedCity INVEST Precision Medicine is an executive summit that gathers thought leaders and investors from across healthcare sectors to discuss new developments in precision medicine, investment trends, and how health IT, diagnostics and biopharma technology are being used to improve outcomes.
Based in Denver, Colorado, SmartTab is engaged in the design, development and validation of next generation wireless drug delivery systems. The SmartTab technology platform is a personalized wireless solution comprised of an ingestible capsule with a microprocessor, smart polymer actuator, and active ingredients. SmartTab is on a mission to provide novel effective therapies to improve patient outcomes and compliance.
Enter your email to stay up to date:
Copyright © 2021 Veloce Corporation | The SmartTab Drug Delivery Platform is a candidate medical product and uses are not approved, cleared, or licensed under sections 505, 510(k), and/or 515 of the FD&C Act. Investigational and not available for commercial sale. | . All rights reserved.